SpyGlass Pharma Appoints Shannon Treviño as General Counsel
SpyGlass Pharma appointed Shannon Treviño as General Counsel, effective immediately. Treviño previously served as General Counsel at Inari Medical, where she helped guide the company through its $4.9 billion acquisition by Stryker.
Key figures
- Inari acquisition value
- $4.9 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.